Company: Principals
Julie E. Goodman, Ph.D., DABT
Dr. Goodman is the Director of Epidemiology at Gradient and an adjunct faculty member in the Department of Epidemiology at the Harvard School of Public Health. She is also a board-certified toxicologist. Dr. Goodman’s focus is on human health risks from chemicals in the environment and consumer products. Her primary responsibilities include the design, oversight, analysis, and interpretation of epidemiology studies, and the evaluation of chemical toxicology data, apparent disease clusters, and chemical exposures. Before joining Gradient, Dr. Goodman was a Cancer Prevention Fellow at the National Cancer Institute, where she conducted molecular epidemiology studies on colon cancer risk. She was also instrumental in the development of Polymorphism Interaction Analysis, a powerful statistical tool for cancer risk assessment. Dr. Goodman has published the results of her analyses in peer-reviewed toxicology and epidemiology journals, and has presented them to community groups and regulatory and legislative bodies.
